UPC
Universe Pharmaceuticals Inc. Ordinary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
UPC Stock Analysis: Buy, Sell, or Hold?
$1.51
-0.02 (-1.31%)
▼
5d:
+8.63%
30d:
-63.61%
90d:
-73.88%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (88%)
Quality Score
61/100
Position
OVERSOLD
30-Day Fair Range
$1.59 – $4.12
Position: OVERSOLD
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$1.33 / $1.68
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: UPC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When UPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: UPC is currently trading at $1.51, which is considered oversold relative to its 30-day fair value range of $1.59 to $4.12.
Technical Outlook: Technically, UPC is in a downtrend. Immediate support is located at $1.33, while resistance sits at $1.68.
Market Sentiment: UPC scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UPC is in a downtrend. Immediate support is located at $1.33, while resistance sits at $1.68.
Market Sentiment: UPC scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.59 -
$4.12
Company Quality Score
61/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
88.2%
Trading Range & Key Levels
30-Day Trading Range
$1.59 -
$4.12
Current vs Trading Range
OVERSOLD
Support Level
$1.33
Resistance Level
$1.68
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (73/100)
- CAUTION: Bottoming setup, but lagging the sector by 52% over 20 days — wait for relative strength
Fundamental Context
Revenue Growth (YoY)
-1.3%
Earnings Growth (YoY)
-82.0%
Profit Margin
-10.9%
Share UPC Analysis
Share this live UPC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (UPC)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows bullish sentiment towards $UPC with no recent news articles available.
Key Retail Themes:
Anticipation for future price movement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 30 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 39 SELL |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
15 analysts |
$49 | 47 HOLD |
|
AMLX
Amylyx Pharmaceuticals I… |
STRONG BUY
12 analysts |
$43 | 55 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 59 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive UPC Research Pages
